Form 10-Q · Quarterly report

Ametek 10-Q, filed Aug 4, 2026

Filed
CIK
0001037868
Accession no.
0001037868-26-000175
AI-generated summary

Summary

Ametek reported record second-quarter 2026 sales, operating income, net income, orders, and backlog, with net sales up 15.0% to $2,044.4 million and net income up 13.5% to $406.9 million, or $1.77 per diluted share. The quarter included contributions from the FARO Technologies, LKC Technologies, and First Aviation Services acquisitions and $16.2 million of pre-tax acquisition-related integration costs; Ametek also terminated a bridge loan tied to its planned acquisition of Indicor Instrumentation after entering new credit agreements.

Key points

  • Net sales rose 15.0% year over year to a record $2,044.4 million, driven by 10% organic growth and 5% from acquisitions.
  • Orders rose 28.2% to a record $2,284.0 million, and backlog was a record $4,110.2 million at June 30, 2026.
  • Net income rose 13.5% to a record $406.9 million, and diluted EPS rose 14.2% to a record $1.77.
  • Ametek recorded $16.2 million of pre-tax acquisition-related integration costs related to FARO, LKC, and First Aviation.

Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.

From the filing

Item 2. Management’s Discussion Results of Operations For the quarter ended June 30, 2026, the Company posted record sales, operating income, net income, orders, and backlog, as well as strong operating margins. Contributions from the acquisitions of FARO Technologies ("FARO") in July 2025, LKC Technologies ("LKC") in January 2026, and First Aviation Services ("First Aviation") in May 2026, as well as our Operational Excellence initiatives had a positive impact on the second quarter of 2026 results. …

An excerpt of the text as filed with the SEC, cut for length.

Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.

Follow Ametek in Readster

Add Ametek to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.

No credit card. When the trial ends, you move to Readster Free unless you subscribe.